Press Releases

 Filter by Provider

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Oracle Corporation (“Oracle” or the “Company”) (NYSE: ORCL).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

Forum & Social, a new private gathering concept founded by Drew Clark, has announced plans to launch across five Southeastern cities this summer. The venues will open in Atlanta, Charlotte, Jacksonville, Orlando, and Tampa and are designed for organizations that require structured environments for leadership meetings, client hosting, and donor engagement.

Sprouts Farmers Market, Inc. (Nasdaq: SFM), one of the largest and fastest-growing specialty retailers of fresh, natural and organic food in the United States, today announced the company’s participation in the 38th Annual ROTH Conference in Dana Point, CA. Jack Sinclair, chief executive officer, and Curtis Valentine, chief financial officer, are scheduled to conduct a fireside chat discussion at 8:30 a.m. Pacific Time on Tuesday, March 24, 2026.

Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on developing FB102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications, today announced the issuance of equity inducement awards as required by the Nasdaq Stock Market Rules.

Gossamer Bio, Inc. (Nasdaq: GOSS), a biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced its financial results for the fourth quarter and year ended December 31, 2025, and provided a corporate update. Gossamer Bio and the Chiesi Group are jointly developing seralutinib under a global collaboration agreement.

Greg Butz joins Royalty Pharma as Executive Vice President, Partnering & Investments

MIAMI, March 17, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases, today announced that it has commenced an underwritten public offering of shares of its common stock (and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of common stock). SAB BIO also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the of the securities to be sold in the proposed offering at the public offering price, less underwriting discounts and commissions. All of the shares (and any pre-funded warrants) in the proposed offering are to be sold by SAB BIO.

BEDFORD, Mass., March 17, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, announced today that the U.S. Food and Drug Administration (FDA) has extended its review of the New Drug Application (NDA) for LNTH-2501 (Gallium 68 edotreotide) by three months to June 29, 2026. 

The FDA approval of Tirzepatide for children age 10 and older marks one of the most meaningful advances in pediatric metabolic care in a generation. Youth-onset type 2 diabetes progresses faster than adult disease, often overlapping with obesity, insulin resistance, and early cardiovascular risk. California Trim Clinic examines the pivotal clinical evidence behind the approval and explains why this shift in treatment strategy is redefining what treatment can look like for younger patients. For families navigating youth metabolic disease, physician-guided programs such as TeenHealthRx, developed by California Trim Clinic to support adolescents nationwide, are beginning to translate these scientific breakthroughs into real clinical care.

CaoCao Inc. today announced new progress in its Robotaxi operations: the company has activated more than 3,600 virtual pick-up and drop-off points across Hangzhou’s Binjiang District and the central area of Xiaoshan District, achieving near full coverage of major roads, office buildings, and entrances to residential and mixed-use communities within the operating area.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

ORLANDO, FL / ACCESS Newswire / March 17, 2026 / Laser Photonics Corporation (NASDAQ:LASE) (the "Company"), a global leader in laser systems for industrial and defense applications, today announced the closing of its previously announced exercise of certain outstanding warrants to purchase up to an aggregate of 1,373,630 shares of common stock of the Company originally issued in September 2025, having an exercise price of $3.40 per share, at a reduced exercise price of $1.08 per share. The shares of common stock issuable upon exercise of the warrants are registered pursuant to an effective registration statement on Form S-1 (No. 333-290875). The gross proceeds to the Company from the exercise of the warrants were approximately $1.5 million, prior to deducting placement agent fees and estimated offering expenses.

Institutional investors holding positions in monday.com Ltd. (NASDAQ: MNDY) during the period September 17, 2025 through February 6, 2026 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from its boron chemistry platform, today reported financial results for the fourth quarter and year ended December 31, 2025.

Levi & Korsinsky, LLP reminds purchasers of Nektar Therapeutics (NASDAQ: NKTR) securities of a pending securities class action.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of GoDaddy Inc. (“GoDaddy” or the “Company”) (NYSE: GDDY) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of DNOW Inc. (“DNOW” or the “Company”) (NYSE: DNOW) investors concerning the Company’s possible violations of the federal securities laws.

Levi & Korsinsky, LLP reminds purchasers of Soleno Therapeutics, Inc. (NASDAQ: SLNO) securities of a pending securities class action.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Tennant Company (“Tennant” or the “Company”) (NYSE: TNC) investors concerning the Company’s possible violations of the federal securities laws.

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced the promotion of Richard Chen, M.D., M.S., to the position of President. Dr. Chen will continue to serve as CMO of Personalis in addition to his new role.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX) investors concerning the Company’s possible violations of the federal securities laws.

Cohu, Inc. (NASDAQ: COHU), a global supplier of equipment and services optimizing semiconductor manufacturing yield and productivity, today announced a leading U.S. based semiconductor manufacturer and foundry services company placed a multi-unit order for the Eclipse platform to support development and manufacturing of next‑generation high‑performance computing (HPC) and artificial intelligence (AI) datacenter processors.

Levi & Korsinsky, LLP encourages investors who suffered losses in Snowflake Inc. (NYSE: SNOW) to contact the firm. WHO IS AFFECTED: Those who purchased SNOW securities between June 27, 2023 and February 28, 2024 may be entitled to recover damages. Find out if you are eligible to recover losses. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Levi & Korsinsky, LLP alerts investors in NuScale Power Corporation (NYSE: SMR) of a pending securities class action naming two senior executives as individual defendants under Section 20(a) of the Securities Exchange Act of 1934. Find out if you qualify to recover losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com | (212) 363-7500.

On January 9, 2026, Cantor slashed its price target on Aquestive Therapeutics, Inc. (NASDAQ: AQST) from $15 to $8, warning that "the history of CRLs following similar letters increases the risk of a potential delay for Anaphylm." Shareholders who purchased AQST securities between June 16, 2025 and January 8, 2026 lost over 37% of their investment value in a single trading session. Find out if you qualify to recover your investment losses. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Stephen Pakola, M.D., REGENXBIO's (NASDAQ: RGNX) Executive Vice President and Chief Medical Officer, is named as an individual defendant in a securities class action alleging that his repeated public assurances about the safety of RGX-111 gene therapy concealed material risks from investors. When the truth emerged on January 28, 2026, RGNX shares fell $2.40 per share, a decline of 17.8%, closing at $11.01.

The promise: guaranteed returns of 80% to 300% on a stock poised for acquisition at a premium. The reality: a 94.1% single-day collapse that destroyed $950 million in market capitalization, leaving thousands of investors across six countries holding shares worth pennies.

Ecolab will host a live webcast to discuss its first quarter 2026 results. A news release containing first quarter results is expected to be issued before market open on April 28, 2026.

Oklo Inc. (NYSE: OKLO) (“Oklo” or “the Company”), an advanced nuclear technology company, today published its financial results and business update for the quarter and year ended December 31, 2025.

Levi & Korsinsky, LLP reminds purchasers of Boston Scientific Corporation (NYSE: BSX) securities of a pending securities class action.

Institutional investors holding positions in Enphase Energy, Inc. (NASDAQ: ENPH) during the period April 22, 2025 through October 28, 2025 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Levi & Korsinsky, LLP examines the adequacy of Franklin BSP Realty Trust, Inc.'s (NYSE: FBRT) risk disclosures during the period November 5, 2024 through February 11, 2026. Shareholders who lost money on FBRT may find out if you are eligible to pursue a recovery claim or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Reddit, Inc. (NYSE: RDDT) failed to manage Reddit in an acceptable manner, breaching their fiduciary duties to Reddit, and whether Reddit and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know:

Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of PepsiCo, Inc. (NASDAQ: PEP) failed to manage PepsiCo in an acceptable manner, breaching their fiduciary duties to PepsiCo, and whether PepsiCo and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know:

Levi & Korsinsky, LLP announces that a securities class action has been filed against Camping World Holdings, Inc. (NYSE: CWH).

Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of UnitedHealth Group Incorporated (NYSE: UNH) failed to manage UnitedHealth Group in an acceptable manner, breaching their fiduciary duties to UnitedHealth Group, and whether UnitedHealth Group and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know:

Levi & Korsinsky, LLP announces that a securities class action has been filed against Lakeland Industries, Inc. (NASDAQ: LAKE).

Levi & Korsinsky, LLP reminds purchasers of Eos Energy Enterprises, Inc. (NASDAQ: EOSE) securities of a pending securities class action.

Levi & Korsinsky, LLP reminds purchasers of Trip.com Group Limited (NASDAQ: TCOM) securities of a pending securities class action.

Levi & Korsinsky, LLP announces that a securities class action has been filed against Driven Brands Holdings Inc. (NASDAQ: DRVN).

Levi & Korsinsky, LLP alerts investors in Apollo Global Management, Inc. (NYSE: APO) of a pending securities class action naming two senior figures as individual defendants. Find out if you qualify to recover losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Institutional investors holding positions in Navan, Inc. (Nasdaq: NAVN) acquired pursuant or traceable to the Company's October 31, 2025 initial public offering may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Blue Owl Capital Inc. (NYSE: OWL) failed to manage Blue Owl in an acceptable manner, breaching their fiduciary duties to Blue Owl, and whether Blue Owl and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know:

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Richtech Robotics Inc. (“Richtech” or the “Company”) (NASDAQ: RR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

SAN DIEGO, March 17, 2026 (GLOBE NEWSWIRE) -- Quick Custom Intelligence (QCI) today announced the launch of Agentic QCI Resorts, the next evolution of its flagship platform, embedding large language models (LLMs) directly into casino operations through a secure, on-premise architecture.

TekSynap, a leading provider of IT solutions supporting government and defense missions, today announced the appointment of Fabian Plath as Growth and Corporate Development Lead.

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Inovio Pharmaceuticals, Inc. (“Inovio” or the “Company”) (NASDAQ: INO) and certain officers.   The class action, filed in the United States District Court for the Eastern District of Pennsylvania, and docketed under 26-cv-00803, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Inovio securities between October 10, 2023 and December 26, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

Debut author Albert Lord is here to present his debut book, “ The Road of Vultures,” the electrifying first novel in The Vengeful Warrior Trilogy. With this initial book, this series promises a gritty epic fantasy that will captivate fans of Brandon Sanderson, Joe Abercrombie, and George R.R. Martin. From dark magic, political intrigue, and revenge to action-packed drama, it has everything you need to keep reading until the very end.

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Ramaco Resources, Inc. (“Ramaco” or the “Company”) (NASDAQ: METC).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.